BioCentury
ARTICLE | Company News

Concateno, Cozart deal

September 10, 2007 7:00 AM UTC

Alcohol and drug testing company COT will acquire CZT for £64.4 million ($130 million) in cash. The acquisition price of 57.5p per share is a 39% premium to CZT's close of 41.5p on Monday, the day bef...